Help manage your platelet levels with TAVALISSE
TAVALISSE has been shown to raise platelet counts over time in clinical trials
In a study of 150 adults with chronic ITP, TAVALISSE was compared to placebo (a sugar pill) to see how effective it was in raising platelet counts over 6 months. All study patients had at least one prior treatment, such as steroids, immunoglobulins, rituximab, a thrombopoietin receptor agonist, and/or splenectomy. Patients who benefited from TAVALISSE responded to the drug regardless of prior treatment.
PLATELET COUNT RESPONSE
A subset of patients, those with a stable response* to TAVALISSE, achieved a median platelet count of approximately 97,000 per microliter at the end of the 6-month study. The median starting platelet count for these patients was 16,000 per microliter.
*Stable response in the clinical trial was defined as a platelet count greater than or equal to 50,000 per microliter for 4 (or more) doctor visits during the last 3 months of the 6-month study.
TIME TO RESPONSE
Many patients who had a positive response with TAVALISSE saw an increase in their platelet counts at their first check-in (approximately 2 weeks).
Your healthcare provider will monitor your platelet counts and make any necessary adjustments that are right for you.
DURATION OF RESPONSE
In an ongoing clinical trial, the duration of response was maintained for over 2 years in more than half of responders.†
†Estimate of the median duration of response.
MONITORING YOUR RESPONSE
Your healthcare provider will monitor your platelet counts, watch for potential side effects, and may adjust your treatment to help you reach your goals.
TAVALISSE is a medicine that you take daily, as prescribed
- Your healthcare provider will advise you to keep taking TAVALISSE for as long as it maintains your platelet counts and you respond well to therapy.
- ITP is a chronic condition, so it’s important to take TAVALISSE every day to manage your platelet counts, even if you start to feel better.
- If changes to your dose or medicine are needed, your healthcare provider will discuss this with you.